Whole genome association studies: Deciding when persistence becomes perseveration
2007; Wiley; Volume: 147B; Issue: 2 Linguagem: Inglês
10.1002/ajmg.b.30568
ISSN1552-485X
AutoresJohn Hardy, Nancy Low, Andrew Singleton,
Tópico(s)Genetic Associations and Epidemiology
ResumoAmerican Journal of Medical Genetics Part B: Neuropsychiatric GeneticsVolume 147B, Issue 2 p. 131-133 Editorial Whole genome association studies: Deciding when persistence becomes perseveration† John Hardy, Corresponding Author John Hardy [email protected] Laboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, Maryland Reta Lila Weston Laboratories & Department of Molecular Neuroscience, Institute of Neurology UCL, Queen Square, London, UKLaboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, MD 20892-3707.Search for more papers by this authorNancy Low, Nancy Low Department of Psychiatry, McGill University, 1033 Pine Avenue West, Montreal, Quebec, Canada Section on Developmental Genetic Epidemiology, National Institute of Mental Health, Bethesda, MarylandSearch for more papers by this authorAndrew Singleton, Andrew Singleton Laboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, MarylandSearch for more papers by this author John Hardy, Corresponding Author John Hardy [email protected] Laboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, Maryland Reta Lila Weston Laboratories & Department of Molecular Neuroscience, Institute of Neurology UCL, Queen Square, London, UKLaboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, MD 20892-3707.Search for more papers by this authorNancy Low, Nancy Low Department of Psychiatry, McGill University, 1033 Pine Avenue West, Montreal, Quebec, Canada Section on Developmental Genetic Epidemiology, National Institute of Mental Health, Bethesda, MarylandSearch for more papers by this authorAndrew Singleton, Andrew Singleton Laboratory of Neurogenetics, NIA, Porter Neuroscience Building, MSC3707, NIH Main Campus, Bethesda, MarylandSearch for more papers by this author First published: 31 May 2007 https://doi.org/10.1002/ajmg.b.30568Citations: 4 † Please cite this article as follows: Hardy J, Low N, Singleton A. 2008. Whole Genome Association Studies: Deciding When Persistence Becomes Perseveration. Am J Med Genet Part B 147B:131–133. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. 2007. The consortium on the genetics of endophenotypes in schizophrenia: Model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull 33(1): 33–48. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A. 1998. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen. Brain 121(Pt 10): 1869–1887. Clayton D, McKeigue PM. 2001. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358(9290): 1356–1360. Conway KP, Compton W, Stinson FS, Grant BF. 2006. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 67(2): 247–257. Craddock N, Forty L. 2006. Genetics of affective (mood) disorders. Eur J Hum Genet 14(6): 660–668. DeLisi LE, Faraone SV. 2006. When is a “positive” association truly a “positive” in psychiatric genetics? A commentary based on issues debated at the World Congress of Psychiatric Genetics, Boston, October 12–18, 2005. Am J Med Genet Part B 141B(4): 319–322. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A. 2006. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol 5(11): 911–916. Gibbs JR, Singleton A. 2006. Application of genome-wide single nucleotide polymorphism typing: Simple association and beyond. PLoS Genet 2(10): 151–157. Gulcher JR, Kong A, Stefansson K. 2001. The role of linkage studies for common diseases. Curr Opin Genet Dev 11(3): 264–267. Hardy J. 2006. Bad luck: An unappreciated limitation in the interpretation of twin studies. Am J Med Genet Part B 141B(6): 681. Hardy J, Myers A, Wavrant-De Vrieze F. 2004. Problems and solutions in the genetic analysis of late-onset Alzheimer's disease. Neurodegener Dis 1(4–5): 213–217. Insel TR, Collins FS. 2003. Psychiatry in the genomics era. Am J Psychiatry 160(4): 616–620. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51(1): 8–19. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6): 617–627. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308: 385–389. Merikangas KR, Risch N. 2003. Genomic priorities and public health. Science 302(5645): 599–601. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J. Zurich Cohort Study. 2003. Longitudinal trajectories of depression and anxiety in a prospective community study: The Zurich Cohort Study. Arch Gen Psychiatry 60(10): 993–1000. Riley B, Kendler KS. 2006. Molecular genetic studies of schizophrenia. Eur J Hum Genet 14(6): 669–680. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273(5281): 1516–1517. Schork NJ, Greenwood TA, Braff DL. 2007. Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research. Schizophr Bull 33(1): 95–104. Todd JA. 2006. Statistical false positive or true disease pathway? Nat Genet 38(7): 731–733. Van Den Bogaert A, Del-Favero J, Van Broeckhoven C. 2006. Major affective disorders and schizophrenia: A common molecular signature? Hum Mutat 27(9): 833–853. Wang WY, Barratt BJ, Clayton DG, Todd JA. 2005. Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 6(2): 109–118. Citing Literature Volume147B, Issue25 March 2008Pages 131-133 ReferencesRelatedInformation
Referência(s)